Switch to:
Also traded in: Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.02
UHID's Cash-to-Debt is ranked lower than
95% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 0.49 vs. UHID: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
UHID' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: N/A
Current: 0.02
Equity-to-Asset 0.45
UHID's Equity-to-Asset is ranked lower than
55% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. UHID: 0.45 )
Ranked among companies with meaningful Equity-to-Asset only.
UHID' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.42 Max: 0.55
Current: 0.45
0.26
0.55
Interest Coverage 11.03
UHID's Interest Coverage is ranked higher than
58% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 8.43 vs. UHID: 11.03 )
Ranked among companies with meaningful Interest Coverage only.
UHID' s Interest Coverage Range Over the Past 10 Years
Min: 5.19  Med: 9.13 Max: 48.57
Current: 11.03
5.19
48.57
Piotroski F-Score: 7
Altman Z-Score: 2.55
Beneish M-Score: -2.71
WACC vs ROIC
5.89%
10.12%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 12.88
UHID's Operating Margin % is ranked higher than
68% of the 266 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. UHID: 12.88 )
Ranked among companies with meaningful Operating Margin % only.
UHID' s Operating Margin % Range Over the Past 10 Years
Min: 7.91  Med: 13.04 Max: 13.93
Current: 12.88
7.91
13.93
Net Margin % 7.23
UHID's Net Margin % is ranked higher than
64% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.39 vs. UHID: 7.23 )
Ranked among companies with meaningful Net Margin % only.
UHID' s Net Margin % Range Over the Past 10 Years
Min: 3.64  Med: 6.13 Max: 7.53
Current: 7.23
3.64
7.53
ROE % 16.12
UHID's ROE % is ranked higher than
73% of the 249 Companies
in the Global Medical Care industry.

( Industry Median: 9.35 vs. UHID: 16.12 )
Ranked among companies with meaningful ROE % only.
UHID' s ROE % Range Over the Past 10 Years
Min: 11.67  Med: 15.9 Max: 18.6
Current: 16.12
11.67
18.6
ROA % 7.24
UHID's ROA % is ranked higher than
72% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.86 vs. UHID: 7.24 )
Ranked among companies with meaningful ROA % only.
UHID' s ROA % Range Over the Past 10 Years
Min: 4.01  Med: 5.89 Max: 7.32
Current: 7.24
4.01
7.32
ROC (Joel Greenblatt) % 28.28
UHID's ROC (Joel Greenblatt) % is ranked higher than
65% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 16.56 vs. UHID: 28.28 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
UHID' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 15.97  Med: 23.03 Max: 28.88
Current: 28.28
15.97
28.88
3-Year Revenue Growth Rate 10.20
UHID's 3-Year Revenue Growth Rate is ranked higher than
60% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. UHID: 10.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
UHID' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -4.2  Med: 10.4 Max: 19.4
Current: 10.2
-4.2
19.4
3-Year EBITDA Growth Rate 11.40
UHID's 3-Year EBITDA Growth Rate is ranked higher than
59% of the 169 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. UHID: 11.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
UHID' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -3.3  Med: 13.8 Max: 26.7
Current: 11.4
-3.3
26.7
3-Year EPS without NRI Growth Rate 11.60
UHID's 3-Year EPS without NRI Growth Rate is ranked higher than
59% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 7.50 vs. UHID: 11.60 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
UHID' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -11.3  Med: 20.5 Max: 73.8
Current: 11.6
-11.3
73.8
GuruFocus has detected 1 Warning Sign with Universal Health Services Inc $UHID.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» UHID's 30-Y Financials

Financials (Next Earnings Date: 2017-07-25 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NYSE:DVA, NAS:WOOF, NYSE:EVHC, NYSE:MD, NYSE:HLS, NAS:ACHC, NYSE:CHE, NAS:LPNT, NAS:AMED, NYSE:SEM » details
Traded in other countries:UHS.Germany, UHS.USA,
Headquarter Location:USA
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers.

Universal Health Services owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers. Each segment contributes roughly half of the firm's overall revenue. Universal Health Services receives a significant portion of its net patient revenue from Medicare and Medicaid. The largest proportion of the firm's net patient revenue is paid by managed care organizations.

Top Ranked Articles about Universal Health Services Inc

Universal Health Services, Inc. To Present At The Goldman Sachs 38th Annual Global Healthcare Conference
Universal Health Services, Inc. To Present At The UBS Global Healthcare Conference
Universal Health Services, Inc. To Present At The Bank Of America Merrill Lynch 2017 Healthcare Conference
Universal Health Services, Inc. to Present at the Deutsche Bank 42nd Annual Healthcare Conference
Universal Health Services, Inc. Announces Date For First Quarter 2017 Earnings Release And Conference Call
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Universal Health Services, Inc. (UHS) and Lead Plaintiff Deadline: February 21, 2017

NEW YORK, Feb. 20, 2017 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Universal Health Services, Inc. (“Universal Health” or the “Company”) (NYSE:NYSE:UHS) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased Universal Health securities from February 26, 2015 through December 7, 2016, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/uhs. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”). The Complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Universal Health admitted patients based on its own financial considerations and not the patient’s medical needs; (2) Universal Health would keep patients admitted until their insurance payments ran out in order to bill for the maximum of its services; (3) accordingly, Universal Health’s revenues from inpatient care relied on unjustifiable practices; (4) due to the aforementioned, Universal Health lacked efficient internal control regarding its practices and policies of admitting patients; and (5) consequently, Universal Health’s public statements were materially false and misleading at all relevant times. On December 7, 2016 BuzzFeed released its investigation into Universal Health “…based on interviews with 175 current and former UHS staff, including 18 executives who ran UHS hospitals; more than 120 additional interviews with patients, government investigators, and other experts; and a cache of internal documents.” BuzzFeed reported that “[c]urrent and former employees from at least 10 UHS hospitals in nine states said they were under pressure to fill beds by almost any method – which sometimes meant exaggerating people’s symptoms or twisting their words to make them seem suicidal – and to hold them until their insurance payments ran out.” Following this news, Universal Health stock dropped $15.01 per share or nearly 12% to close at $111.36 on December 7, 2016. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/uhs  or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Universal Health you have until February 21, 2017 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

Read more...
UNIVERSAL HEALTH 96 HOUR DEADLINE ALERT: APPROXIMATELY 96 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Universal Health Services, Inc. – (UHS)
NEW ORLEANS, Feb. 17, 2017 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until February 21, 2017 to file lead plaintiff applications in a securities class action lawsuit against Universal Health Services, Inc. (NYSE:NYSE:UHS). Investor losses must relate to purchases of the Company’s shares between February 26, 2015 and December 7, 2016.  This action is pending in the United States District Court for the Central District of California.What You May DoIf you purchased securities of Universal Health and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]). If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by February 21, 2017. About Kahn Swick & Foti, LLCKSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
206 Covington St.
Madisonville, LA 70447

Read more...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Universal Health Services, Inc. of Class Action Lawsuit and Upcoming Deadline – UHS

NEW YORK, Feb. 13, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Universal Health Services, Inc. (“Universal Health” or the “Company”) (NYSE:NYSE:UHS) and certain of its officers. The class action, filed in United States District Court, Central District of California, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Universal Health securities between February 26, 2015 and December 7, 2016, both dates inclusive (the “Class Period”), seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.
If you are a shareholder who purchased Universal Health securities during the Class Period, you have until February 21, 2017 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.  [Click here to join this class action] Universal Health, through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that:  (1) Universal Health admitted patients based on its own financial considerations and not upon the medical necessity of the patient; (2) Universal Health would keep patients admitted until their insurance payments ran out in order to ensure the maximum payment for its services; (3) as a result, Universal Health's revenues from inpatient care relied on unsustainable practices; (4) in turn, Universal Health lacked effective internal control concerning its practices and policies of admitting patients; and (5) as a result, Universal Health's public statements were materially false and misleading at all relevant times. On December 7, 2016, BuzzFeed published an article titled “Intake”, detailing its year-long investigation into Universal Health, which was “based on interviews with 175 current and former UHS staff, including 18 executives who ran UHS hospitals; more than 120 additional interviews with patients, government investigators, and other experts; and a cache of internal documents.” The report stated that “[c]urrent and former employees from at least 10 UHS hospitals in nine states said they were under pressure to fill beds by almost any method – which sometimes meant exaggerating people’s symptoms or twisting their words to make them seem suicidal – and to hold them until their insurance payments ran out.” The report further stated that “[t]wo dozen current and former employees from 14 UHS facilities across the country told BuzzFeed News that the rule was to keep patients until their insurance ran out in order to get the maximum payment,” and that “scores of employees from at least a dozen UHS hospitals said those facilities tried to keep beds filled even at the expense of the safety of their staff or the rights of the patients they were locking up.” The report also quoted Rick Buckelew, a Universal Health employee who ran Austin Lakes Hospital in Texas until 2014, who stated that “[i]f an insurance company gave you so many days, you were expected to keep the patient there that many days” and that this “was a ‘common practice’ that was openly discussed in regional conferences as well as phone calls with hospital executives.” On this news, shares of Universal Health’s share price fell $15.01, or nearly 12% from its previous closing price, to close at $111.36 on December 7, 2016, damaging investors. The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]

Read more...
LESS THAN ONE MONTH REMAINS FOR UNIVERSAL HEALTH SERVICES INVESTORS: Hagens Berman Reminds Universal Health Services Investors of Approaching Lead Plaintiff Deadline

SAN FRANCISCO, Jan. 24, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Universal Health Services, Inc. (NYSE:NYSE:UHS) of the February 21, 2017 Lead Plaintiff deadline.
If you purchased or otherwise acquired securities of UHS between February 26, 2015 and December 7, 2016 and suffered over $50,000 in losses contact Hagens Berman Sobol Shapiro LLP.  For more information visit: https://www.hbsslaw.com/cases/UHS or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected]. On December 7, 2016, BuzzFeed published an article entitled “Intake” detailing its year-long investigation into Universal Health Services facilities that were allegedly maximizing profits through illegal practices.  UHS allegedly failed to disclose in SEC filings that (1) it improperly admitted patients to its facilities based on its own financial needs rather than based on medical necessity; (2) it improperly kept patients admitted until insurance payments expired; and (3) it lacked sufficient internal controls over patient admissions practices and policies. News of UHS’s allegedly improper actions drove the price of Company shares down approximately 12% that day to close at $111.36 per share.  The Company has publicly denied the accusations made in the BuzzFeed article. “We’re focused on the matters published by BuzzFeed and the ongoing Federal investigation into UHS, all in the context of UHS’ reported history of False Claims Act settlements,” said Hagens Berman partner Reed Kathrein. Whistleblowers: Persons with non-public information regarding UHS should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected]. About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000

Read more...
UHS LOSS ALERT: Rosen Law Firm Reminds Universal Health Services, Inc. Investors of Important Deadline in Class Action Filed by Firm - UHS

NEW YORK, Jan. 24, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Universal Health Services, Inc. securities (NYSE:NYSE:UHS) from February 26, 2015 through December 7, 2016, both dates inclusive (the “Class Period”) of the important February 21, 2017 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Universal Health investors under the federal securities laws. To join the Universal Health class action, go to http://www.rosenlegal.com/cases-1008.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Universal Health admitted patients based on its own financial considerations and not upon the medical necessity of the patient; (2) Universal Health would keep patients admitted until their insurance payments ran out in order to ensure the maximum payment for its services; (3) as a result, Universal Health’s revenues from inpatient care relied on unsustainable practices; (4) in turn, Universal Health lacked effective internal control concerning its practices and policies of admitting patients; and (5) as a result, Universal Health’s public statements were materially false and misleading at all relevant times. On December 7, 2016, Buzzfeed published an investigative story on Universal Health alleging, among other things, that Universal Health put profits ahead of people. On this news, shares of Universal Health fell $15.01 per share, or nearly 12%, from its previous closing price to close at $111.36 per share on December 7, 2016, damaging investors. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 21, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1008.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected]. Attorney Advertising.  Prior results do not guarantee a similar outcome. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

Read more...

Ratios

vs
industry
vs
history
PE Ratio 15.75
UHID's PE Ratio is ranked higher than
81% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 25.92 vs. UHID: 15.75 )
Ranked among companies with meaningful PE Ratio only.
UHID' s PE Ratio Range Over the Past 10 Years
Min: 8.1  Med: 15.25 Max: 25.04
Current: 15.75
8.1
25.04
Forward PE Ratio 15.63
UHID's Forward PE Ratio is ranked higher than
79% of the 63 Companies
in the Global Medical Care industry.

( Industry Median: 20.62 vs. UHID: 15.63 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 15.75
UHID's PE Ratio without NRI is ranked higher than
85% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 26.11 vs. UHID: 15.75 )
Ranked among companies with meaningful PE Ratio without NRI only.
UHID' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.26  Med: 15.83 Max: 43.19
Current: 15.75
8.26
43.19
Price-to-Owner-Earnings 12.52
UHID's Price-to-Owner-Earnings is ranked higher than
83% of the 107 Companies
in the Global Medical Care industry.

( Industry Median: 26.64 vs. UHID: 12.52 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
UHID' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.55  Med: 15.7 Max: 412.27
Current: 12.52
7.55
412.27
PB Ratio 2.36
UHID's PB Ratio is ranked higher than
53% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. UHID: 2.36 )
Ranked among companies with meaningful PB Ratio only.
UHID' s PB Ratio Range Over the Past 10 Years
Min: 1.01  Med: 2.14 Max: 3.54
Current: 2.36
1.01
3.54
PS Ratio 1.14
UHID's PS Ratio is ranked higher than
67% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. UHID: 1.14 )
Ranked among companies with meaningful PS Ratio only.
UHID' s PS Ratio Range Over the Past 10 Years
Min: 0.33  Med: 0.79 Max: 1.68
Current: 1.14
0.33
1.68
Price-to-Free-Cash-Flow 14.88
UHID's Price-to-Free-Cash-Flow is ranked higher than
73% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 24.52 vs. UHID: 14.88 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
UHID' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.57  Med: 15.72 Max: 342.44
Current: 14.88
8.57
342.44
Price-to-Operating-Cash-Flow 8.72
UHID's Price-to-Operating-Cash-Flow is ranked higher than
75% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 14.98 vs. UHID: 8.72 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
UHID' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.2  Med: 8.51 Max: 24.67
Current: 8.72
3.2
24.67
EV-to-EBIT 11.92
UHID's EV-to-EBIT is ranked higher than
84% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 20.37 vs. UHID: 11.92 )
Ranked among companies with meaningful EV-to-EBIT only.
UHID' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.2  Med: 11.75 Max: 26
Current: 11.92
6.2
26
EV-to-EBITDA 8.93
UHID's EV-to-EBITDA is ranked higher than
80% of the 226 Companies
in the Global Medical Care industry.

( Industry Median: 15.18 vs. UHID: 8.93 )
Ranked among companies with meaningful EV-to-EBITDA only.
UHID' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.3  Med: 8.6 Max: 12.2
Current: 8.93
4.3
12.2
PEG Ratio 1.91
UHID's PEG Ratio is ranked higher than
69% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 3.23 vs. UHID: 1.91 )
Ranked among companies with meaningful PEG Ratio only.
UHID' s PEG Ratio Range Over the Past 10 Years
Min: 0.35  Med: 1.13 Max: 18
Current: 1.91
0.35
18
Shiller PE Ratio 25.18
UHID's Shiller PE Ratio is ranked higher than
55% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 28.86 vs. UHID: 25.18 )
Ranked among companies with meaningful Shiller PE Ratio only.
UHID' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.14  Med: 21.95 Max: 40.79
Current: 25.18
10.14
40.79
Current Ratio 1.14
UHID's Current Ratio is ranked lower than
60% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. UHID: 1.14 )
Ranked among companies with meaningful Current Ratio only.
UHID' s Current Ratio Range Over the Past 10 Years
Min: 0.95  Med: 1.41 Max: 1.98
Current: 1.14
0.95
1.98
Quick Ratio 1.06
UHID's Quick Ratio is ranked lower than
59% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. UHID: 1.06 )
Ranked among companies with meaningful Quick Ratio only.
UHID' s Quick Ratio Range Over the Past 10 Years
Min: 0.82  Med: 1.3 Max: 1.78
Current: 1.06
0.82
1.78
Days Inventory 42.11
UHID's Days Inventory is ranked lower than
76% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 15.65 vs. UHID: 42.11 )
Ranked among companies with meaningful Days Inventory only.
UHID' s Days Inventory Range Over the Past 10 Years
Min: 9.58  Med: 42.75 Max: 45.46
Current: 42.11
9.58
45.46
Days Sales Outstanding 53.22
UHID's Days Sales Outstanding is ranked lower than
67% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. UHID: 53.22 )
Ranked among companies with meaningful Days Sales Outstanding only.
UHID' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.28  Med: 53.19 Max: 62.41
Current: 53.22
42.28
62.41
Days Payable 152.30
UHID's Days Payable is ranked higher than
83% of the 165 Companies
in the Global Medical Care industry.

( Industry Median: 44.51 vs. UHID: 152.30 )
Ranked among companies with meaningful Days Payable only.
UHID' s Days Payable Range Over the Past 10 Years
Min: 24.51  Med: 117.93 Max: 155.6
Current: 152.3
24.51
155.6

Buy Back

vs
industry
vs
history
3-Year Dividend Growth Rate 26.00
UHID's 3-Year Dividend Growth Rate is ranked higher than
76% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 11.60 vs. UHID: 26.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
UHID' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 58.7
Current: 26
0
58.7
3-Year Average Share Buyback Ratio 0.60
UHID's 3-Year Average Share Buyback Ratio is ranked higher than
84% of the 142 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. UHID: 0.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UHID' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -6.3  Med: 1.2 Max: 3.6
Current: 0.6
-6.3
3.6

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 11.76
UHID's Price-to-Tangible-Book is ranked lower than
88% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 3.78 vs. UHID: 11.76 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
UHID' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.84  Med: 3.98 Max: 317.57
Current: 11.76
0.84
317.57
Price-to-Intrinsic-Value-Projected-FCF 0.99
UHID's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
83% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 1.96 vs. UHID: 0.99 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
UHID' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.72  Med: 1.17 Max: 33.96
Current: 0.99
0.72
33.96
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.59
UHID's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
94% of the 35 Companies
in the Global Medical Care industry.

( Industry Median: 1.63 vs. UHID: 0.59 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.44
UHID's Price-to-Median-PS-Value is ranked lower than
73% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 1.07 vs. UHID: 1.44 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
UHID' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.11  Med: 0.95 Max: 2.08
Current: 1.44
0.11
2.08
Price-to-Peter-Lynch-Fair-Value 1.75
UHID's Price-to-Peter-Lynch-Fair-Value is ranked higher than
57% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 2.14 vs. UHID: 1.75 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
UHID' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.4  Med: 1.39 Max: 3.71
Current: 1.75
0.4
3.71
Price-to-Graham-Number 2.87
UHID's Price-to-Graham-Number is ranked lower than
61% of the 136 Companies
in the Global Medical Care industry.

( Industry Median: 2.51 vs. UHID: 2.87 )
Ranked among companies with meaningful Price-to-Graham-Number only.
UHID' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.56  Med: 1.81 Max: 12.53
Current: 2.87
0.56
12.53
Earnings Yield (Greenblatt) % 8.39
UHID's Earnings Yield (Greenblatt) % is ranked higher than
87% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.89 vs. UHID: 8.39 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
UHID' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.8  Med: 8.5 Max: 16.1
Current: 8.39
3.8
16.1
Forward Rate of Return (Yacktman) % 14.56
UHID's Forward Rate of Return (Yacktman) % is ranked higher than
63% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: 10.95 vs. UHID: 14.56 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
UHID' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4.4  Med: 18.25 Max: 30.8
Current: 14.56
4.4
30.8

More Statistics

Revenue (TTM) (Mil) $9,929.27
EPS (TTM) $ 7.33
Beta0.26
Short Percentage of Float0.00%
52-Week Range $106.43 - 148.61
Shares Outstanding (Mil)96.69

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 11,007 11,723 12,442
EPS ($) 7.94 8.74 9.45
EPS without NRI ($) 7.94 8.74 9.45
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($) 0.20 0.20 0.20
» More Articles for UHID

Headlines

Articles On GuruFocus.com
Universal Health Services, Inc. To Present At The Goldman Sachs 38th Annual Global Healthcare Confer Jun 08 2017 
Universal Health Services, Inc. To Present At The UBS Global Healthcare Conference May 16 2017 
Universal Health Services, Inc. To Present At The Bank Of America Merrill Lynch 2017 Healthcare Conf May 10 2017 
Universal Health Services, Inc. to Present at the Deutsche Bank 42nd Annual Healthcare Conference Apr 27 2017 
Universal Health Services, Inc. Announces Date For First Quarter 2017 Earnings Release And Conferenc Apr 11 2017 
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Univers Feb 20 2017 
UNIVERSAL HEALTH 96 HOUR DEADLINE ALERT: APPROXIMATELY 96 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GE Feb 18 2017 
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Unive Feb 13 2017 
LESS THAN ONE MONTH REMAINS FOR UNIVERSAL HEALTH SERVICES INVESTORS: Hagens Berman Reminds Universal Jan 24 2017 
UHS LOSS ALERT: Rosen Law Firm Reminds Universal Health Services, Inc. Investors of Important Deadli Jan 24 2017 

More From Other Websites
Could Universal Health (UHS) Be a Great Stock for Value Investors? Jun 20 2017
Universal Health Grows on Acquisitions, Rising Debt a Drag Jun 19 2017
Universal Health Services, Inc. :UHID-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Jun 16 2017
These 3 Stocks Just Raised Their Dividends Jun 15 2017
UHS faults Oregon's reasoning behind delay of psychiatric hospital decision Jun 13 2017
Universal Health Services, Inc. To Present At The Goldman Sachs 38th Annual Global Healthcare... Jun 08 2017
State approves for-profit firm’s new hospital in partnership with University of Miami Jun 05 2017
Universal Health (UHS) Down 2% Since Earnings Report: Can It Rebound? May 26 2017
Universal Health Services stock drops 5% after report of FBI, Defense Department investigation May 24 2017
Universal Health Services shares slip on report of broader federal probe May 23 2017
Universal Health (UHS) Receives Rating Action from Moody's May 22 2017
Universal Health Services, Inc. -- Moody's Affirms Universal Health Services' Ba1 CFR; stable... May 18 2017
Universal Health Services, Inc. Announces Dividend May 17 2017
Universal Health Services, Inc. To Present At The UBS Global Healthcare Conference May 16 2017
Universal Health Services, Inc. To Present At The Bank Of America Merrill Lynch 2017 Healthcare... May 10 2017
Controversial psychiatric chain still seeking to build Wilsonville hospital May 03 2017
Universal Health Services, Inc. to Present at the Deutsche Bank 42nd Annual Healthcare Conference Apr 27 2017
Universal Health (UHS) Beats on Q1 Earnings, Misses Revenues Apr 26 2017
Universal Health Services (UHS) Reports Mixed Q1 Results Apr 25 2017
Universal Health Services posts 1Q profit Apr 25 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}